Infinity Pharmaceutical (INFI) PT Raised to $8 at B.Riley, Following Clinical Trial

February 11, 2021 1:22 PM EST
Get Alerts INFI Hot Sheet
Price: $3.10 +1.31%

Rating Summary:
    11 Buy, 9 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 11 | New: 74
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

B.Riley analyst Andrew D\'Silva raised the price target on Infinity Pharmaceutical (NASDAQ: INFI) to $8.00 (from $4.50) while maintaining a Buy rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change